BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1892362)

  • 1. The European Stroke Prevention Study (ESPS): results by arterial distribution.
    Sivenius J; Riekkinen PJ; Smets P; Laakso M; Lowenthal A
    Ann Neurol; 1991 Jun; 29(6):596-600. PubMed ID: 1892362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet therapy is effective in the prevention of stroke or death in women: subgroup analysis of the European Stroke Prevention Study (ESPS).
    Sivenius J; Riekkinen PJ; Kilpeläinen H; Laakso M; Penttilä I
    Acta Neurol Scand; 1991 Oct; 84(4):286-90. PubMed ID: 1772001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
    Forbes CD
    Int J Clin Pract; 1997 Jun; 51(4):205-8. PubMed ID: 9287258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
    Rouhl RP; Lodder J
    Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
    Weyrich AS; Skalabrin EJ; Kraiss LW
    Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between aspirin combined with dipyridamole versus aspirin alone within 48 hours after ischemic stroke event for prevention of recurrent stroke and improvement of neurological function: a preliminary study.
    Chairangsarit P; Sithinamsuwan P; Niyasom S; Udommongkol C; Nidhinandana S; Suwantamee J
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S148-54. PubMed ID: 16858953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Stroke Prevention Study. ESPS Group.
    Stroke; 1990 Aug; 21(8):1122-30. PubMed ID: 2202093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of aspirin plus extended-release dipyridamole in preventing recurrent stroke in high-risk populations.
    Sacco RL; Sivenius J; Diener HC
    Arch Neurol; 2005 Mar; 62(3):403-8. PubMed ID: 15767505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention of stroke: does dipyridamole add to aspirin?
    Lowenthal A; Buyse M
    Acta Neurol Belg; 1994; 94(1):24-34. PubMed ID: 8140884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Large trials in the secondary prevention of stroke].
    Gensini GF; Simone I; Pantoni L; Inzitari D
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():102S-109S. PubMed ID: 9004808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The European Stroke Prevention Study (ESPS). Principal end-points. The ESPS Group.
    Lancet; 1987 Dec; 2(8572):1351-4. PubMed ID: 2890951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MATCH results: implications for the internist.
    Lutsep HL
    Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low dose acetylsalicylic acid in secondary prevention of stroke].
    Deecke L; Zeiler K
    Wien Klin Wochenschr; 1993; 105(17):485-7. PubMed ID: 8212707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized clinical trial of pentoxifylline and antiaggregants in recent transient ischemic attacks (TIA). A one year follow-up.
    Herskovits E; Vazquez A; Famulari A; Tamaroff L; Fraiman H; Gonzáles AM; Smud R; Vila J; Matera V
    Ric Clin Lab; 1981; 11 Suppl 1():257-64. PubMed ID: 6765140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin in transient ischemic attacks and minor stroke: a meta-analysis.
    Stachenko SJ; Bravo G; Côté R; Boucher J; Battista RN
    Fam Pract Res J; 1991 Jun; 11(2):179-91. PubMed ID: 1829313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipyridamole-associated headache in stroke patients--interindividual differences?
    Lökk J
    Eur Neurol; 2009; 62(2):109-13. PubMed ID: 19521087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.